AI Therapeutics reports promising Phase II data in ALS
AI Therapeutics reported positive data in a small trial targeting a genetic form of ALS, setting the stage for possible further development.
Taimei Technology WP
Ionis and AstraZeneca report additional positive topline data from a Phase III ATTRv-PN trial
US FDA releases draft guidance for cancer clinical trials
Syneos Health and KX partner for data-driven insights
Duchenne muscular dystrophy: major trials and events to watch in 2023
Merck reports positive data from malignant pleural mesothelioma trial
30 years of failed trials put sepsis on track to be the main cause of death by 2050
More positive data for Daiichi Sankyo and AstraZeneca’s blockbuster drug Enhertu
